RT Journal Article
SR Electronic
T1 Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 244
DO 10.1186/s40425-019-0724-8
VO 7
IS 1
A1 Mullins, Stefanie R.
A1 Vasilakos, John P.
A1 Deschler, Katharina
A1 Grigsby, Iwen
A1 Gillis, Pete
A1 John, Julius
A1 Elder, Matthew J.
A1 Swales, John
A1 Timosenko, Elina
A1 Cooper, Zachary
A1 Dovedi, Simon J.
A1 Leishman, Andrew J.
A1 Luheshi, Nadia
A1 Elvecrog, James
A1 Tilahun, Ashenafi
A1 Goodwin, Richard
A1 Herbst, Ronald
A1 Tomai, Mark A.
A1 Wilkinson, Robert W.
YR 2019
UL http://jitc.bmj.com/content/7/1/244.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.